Telemanagement Doxazosin and finasteride are two drugs commonly used to treat benign prostatic hyperplasia (BPH), a condition marked by enlargement of the prostate gland. In a study of more than 3,000 men, researchers at the University of Texas, and colleagues, have ...
Oncology Update Finasteride cuts prostate cancer risk by around a third but has no effect on overall survival rates, a large US study shows. Men taking finasteride also had a slightly increased risk of high-grade lesions compared with placebo (3.5% vs 3%), data from ... and more »
pharmabiz.com The Post- Finasteride Syndrome Foundation (PFS Foundation) announced the funding of a second major clinical study on post- finasteride syndrome (PFS) at Baylor College of Medicine (BCM) in Houston, Texas. Titled “Genetic and Epigenetic Studies on ...
HealthCanal.com SAN ANTONIO – A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research Center confirms that a drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces ...
News-Medical.net In the NCI-sponsored Prostate Cancer Prevention Trial (PCPT), initial findings from a decade ago showed that the drug finasteride significantly reduce...
Plain Dealer CLEVELAND, Ohio -- New data surrounding a drug used for years to treat an enlarged prostate and male pattern baldness is providing more evidence to show the...
